Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032 - Wikidata - awgldk - TriplyDB

Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032

Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032

http://www.wikidata.org/entity/Q33642396

about

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells.Polygenic effects of common single-nucleotide polymorphisms on life span: when association meets causality.Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation.Cyclin-dependent kinase modulators and cancer therapy.ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer.Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs.

P2860

Q34731333-9CBBC7EC-F699-4BFB-8623-3BD2A2305EEA Q36166448-7C628573-D25F-4EFE-A4ED-B00533578E56 Q37159050-56959002-7CDC-4F11-B1FD-78BFADF924F4 Q38038670-21987822-05BA-4106-A28E-3BD828F2C4F1 Q38752310-8A45B113-6BA7-4248-BCB5-4BA690203685 Q39430033-8979F932-8688-4F0D-8D6C-1983F0F33443 Q39610270-117B1023-D705-4A5F-9A3A-1EB4362E8570 Q41869723-92E85224-D58D-42F5-827A-7D4B7F08641C

P2860

Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032

http://www.wikidata.org/entity/Q33642396

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Chemoprevention of mouse intes ...... ndent kinase inhibitor SNS-032

@ast

Chemoprevention of mouse intes ...... ndent kinase inhibitor SNS-032

@en

type

label

Chemoprevention of mouse intes ...... ndent kinase inhibitor SNS-032

@ast

Chemoprevention of mouse intes ...... ndent kinase inhibitor SNS-032

@en

prefLabel

Chemoprevention of mouse intes ...... ndent kinase inhibitor SNS-032

@ast

Chemoprevention of mouse intes ...... ndent kinase inhibitor SNS-032

@en

P1433

Q33642396-1A0B4565-FF76-403A-A873-2A5B4A216CFC

P1476

Q33642396-2B76D3BB-2B29-422D-BB00-2BDD1AB7CD7F

P2093

Q33642396-3C5AC6EA-C306-4042-B728-754F3801D5B1

Q33642396-8F18CA0D-FEB3-4F0A-9A0D-5723AE0034DF

Q33642396-E863644A-9457-4D4E-8617-C15C554779EC

P2860

Q33642396-218744F9-1AC6-4FBB-AD64-9D7DC0DB9C9E

Q33642396-35DA3401-3221-45B7-A7BF-42FEC9DFE72F

Q33642396-470E734D-FAA9-412C-8E2B-092A7ADE326B

Q33642396-4E9B1AF0-1A18-4FFE-AED3-86ECB7DA266B

Q33642396-57B6A4A6-9203-48A6-BA67-B02948C2BC60

Q33642396-5A87D703-EFC1-45CC-B063-6CD7C8C2D91C

Q33642396-662AB553-D97B-43EC-B4FE-9A013B5EACD2

Q33642396-682CE4A3-B8EC-4625-B5E9-486D79DACAC6

Q33642396-6DB4A569-28C4-4BA1-9BB9-F49CEDE8C49A

Q33642396-6EC81E18-06BA-45EC-8B36-21697B6EB822

P304

Q33642396-C62422EF-79A7-4971-ABB6-AE2F6E14CA38

P31

Q33642396-6043ACB9-31C7-4CBA-981E-03C00AD67ED5

P356

Q33642396-F84F644D-B701-4572-90A1-5279FE307072

P433

Q33642396-1BDB9CC3-81D7-4FE4-B815-DFAE4B3B4A5D

P478

Q33642396-D842AB62-6E9D-4E5F-BA96-2FB5CA16EC55

P577

Q33642396-D4BE9332-A6FB-4703-8977-5AB51290AAF4

P698

Q33642396-EB23E7FE-17B7-464A-8490-809832E61720

P932

Q33642396-03757F44-8D61-47ED-95FA-746585D821B0

P356

1940-6207.CAPR-09-0053

P1433

Cancer Prevention Research

P1476

Chemoprevention of mouse intes ...... ndent kinase inhibitor SNS-032

@en

P2093

Amelie Boquoi

http://www.w3.org/2001/XMLSchema#string

Greg H Enders

http://www.w3.org/2001/XMLSchema#string

Tina Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status

Cyclin-dependent kinase pathways as targets for cancer treatment

The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouse

p27kip1 in intestinal tumorigenesis and chemoprevention in the mouse.

S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.

Primary prevention of colorectal cancer: diet and drugs.

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor

Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol.

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.

P304

800-806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-09-0053

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19723896

http://www.w3.org/2001/XMLSchema#string

P932

2819381

http://www.w3.org/2001/XMLSchema#string